Team Kilimanjaro

After a successful summit of Mt. Everest, Luke Timmerman has set his sights on Mt. Kilimanjaro, the highest peak in Africa. Formed by biotech executives and investors from around the country, Team Kilimanjaro will travel to Tanzania, Africa in July 2019.

Team Kilimanjaro climbers will each raise $50,000 or more to support cancer research at Fred Hutch. The team has already raised $1 million and aims to raise at least another $300,000 before departing for Mt. Kilimanjaro in July.

Climbers:

• Bob More, Partner at Alta Partners

• Praveen Tipirneni, CEO Morphic Therapeutic

• Kelly O'Brien, Vice President of Philanthropy, Fred Hutch

• Zoe Barry, CEO, ZappRx

• Kristin Anderson, Postdoctoral research fellow, Immunology, Fred Hutch

• Bill Newell, CEO, Sutro Biopharma

• Lesley Stolz, EVP & Chief Business Officer, Annexon Biosciences

• Luke Timmerman, Founder and Editor, Timmerman Report

• Simba Gill, CEO, Evelo Biosciences; Venture Partner, Flagship Pioneering

• Heidi Hagen, Chief Strategy Officer and Co-Founder, Vineti

• Kirsten Axelsen, Visiting Fellow American Enterprise Institute and Healthcare Consultant

• Nina Kjellson, General Partner, Canaan Partners

• Uciane Scarlett, Associate, Atlas Venture

• Sandy Zweifach, CEO, Nuvelution Pharma

• Nancy Miller Rich, Chief Executive, Miller-Rich Associates 

• Adam Gridley, President and CEO, Histogenics

• Daniel Bradbury, Chairman and CEO, Equillium

• Senthil Sundaram, Chief Financial Officer, Nightstar Therapeutics

• Nancy Hong, Managing Director, RiverVest Venture Partners

• Ken Brunt, Vice President of Customer Operations, Veracyte

• Julia Owens, CEO, Millendo Therapeutics

• Spencer Guthrie, CEO and Founder, Aurora Bio

• Peter Faroni, Co-founder and Partner, Madryn Asset Management

• Alec More, Student

• Katrine Bosley, Biotech Entrepreneur

• Heather Behanna, Investment consultant, SR One

• Oren Beske, SVP, Corporate Strategy and Development, ATUM

To mail in a donation, please send to the address below, indicating the climber you wish to donate to in the subject line. For stock donations or bank transfer instructions, please email climb@fredhutch.org.

Fred Hutch
ATTN: Climb to Fight Cancer
1100 Fairview Ave N, Mail Stop J5-200
Seattle, WA 98109

Fundraising goal:

$1,300,000 / $50,000 per climber

Elevation:

19,340 feet

Guide service:

Alpine Ascents International (AAI)

Date:

July 17-28, 2019

Sponsors:

Veracyte
Nektar Therapeutics
Alexandria Real Estate Equities
Exact Sciences
Alexion Pharmaceuticals
Alta Partners
ATUM Bio
Biocom
Foundation Medicine
Glaukos Charitable Foundation
Johnson & Johnson Innovation, JLABS
Madryn Asset Management
RiverVest Venture Partners
Servier
Skadden
Sofinnova
Takeda Pharmaceuticals
5AM Ventures
Akcea Therapeutics
Antibody Solutions
Atlas Venture
Blueprint Medicines
Catenion
Cooley
Finsbury
JP Morgan
L.E.K. Consulting
Mirati Therapeutics, Inc
Moore & Van Allen, PLLC
Pfizer
Proskauer
Toft Group
Zymeworks